ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,29355
-0,98%
Bitcoin
69.432,95
0,15%
Brent Oil
79,395
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. HilleVax Inc (HLVX)

  7. HilleVax Inc (HLVX) Notícias

HLVX

HilleVax (HLVX)

HilleVax Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:HLVX
DataHoraFonteTítuloCódigoCompanhia
10/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HLVXHilleVax Inc
09/05/202417:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
09/05/202417:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
09/05/202417:05GlobeNewswire Inc.HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
20/03/202417:00GlobeNewswire Inc.HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
12/02/202421:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
05/02/202418:05GlobeNewswire Inc.HilleVax to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:HLVXHilleVax Inc
26/01/202419:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
18/01/202409:49Dow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
18/01/202409:00GlobeNewswire Inc.HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
08/01/202409:00GlobeNewswire Inc.HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of ChinaNASDAQ:HLVXHilleVax Inc
03/01/202420:28GlobeNewswire Inc.HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
18/12/202319:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
09/11/202318:05GlobeNewswire Inc.HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
01/11/202317:48GlobeNewswire Inc.HilleVax to Present at Upcoming Investor ConferencesNASDAQ:HLVXHilleVax Inc
26/09/202317:01GlobeNewswire Inc.HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
25/09/202308:00GlobeNewswire Inc.HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:HLVXHilleVax Inc
20/09/202317:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HLVXHilleVax Inc
19/09/202321:05GlobeNewswire Inc.HilleVax Announces Pricing of Public Offering of Common StockNASDAQ:HLVXHilleVax Inc
19/09/202317:09GlobeNewswire Inc.HilleVax Announces Proposed Public Offering of Common StockNASDAQ:HLVXHilleVax Inc
14/08/202308:00GlobeNewswire Inc.HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
22/06/202317:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HLVXHilleVax Inc
20/06/202319:07Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:HLVXHilleVax Inc
09/06/202319:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HLVXHilleVax Inc
12/05/202317:56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HLVXHilleVax Inc
12/05/202317:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HLVXHilleVax Inc
12/05/202317:05GlobeNewswire Inc.HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
10/05/202317:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:HLVXHilleVax Inc
09/05/202308:00GlobeNewswire Inc.HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of DirectorsNASDAQ:HLVXHilleVax Inc
28/04/202317:46Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HLVXHilleVax Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:HLVX

Seu Histórico Recente

NASDAQ
AAYSGXX
Goldman Sachs Bank Usa A...
BIT
UC4KSU
Unicredit Bank
ASX
TIL
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados